Related Experiment Video
Updated: Oct 20, 2025
Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
Nanoarchitectonics: Complexes and Conjugates of Platinum Drugs with Silicon Containing Nanocarriers. An Overview
Kinga Piorecka1, Jan Kurjata1, Wlodzimierz A Stanczyk1
1Centre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza 112, 90-363 Lodz, Poland.
Abstract:
The development in the area of novel anticancer prodrugs (conjugates and complexes) has attracted growing attention from many research groups. The dangerous side effects of currently used anticancer drugs, including cisplatin and other platinum based drugs, as well their systemic toxicity is a driving force for intensive search and presents a safer way in delivery platform of active molecules. Silicon based nanocarriers play an important role in achieving the goal of synthesis of the more effective prodrugs. It is worth to underline that silicon based platform including silica and silsesquioxane nanocarriers offers higher stability, biocompatibility of such the materials and pro-longed release of active platinum drugs. Silicon nanomaterials themselves are well-known for improving drug delivery, being themselves non-toxic, and versatile, and tailored surface chemistry. This review summarizes the current state-of-the-art within constructs of silicon-containing nano-carriers conjugated and complexed with platinum based drugs. Contrary to a number of other reviews, it stresses the role of nano-chemistry as a primary tool in the development of novel prodrugs.
Insights
Silicon nanocarriers offer a safer, more effective platform for platinum-based anticancer prodrugs. Their stability and tailored surface chemistry enhance drug delivery, reducing systemic toxicity and improving patient outcomes.
Area of Science:
- Nanotechnology
- Materials Science
- Oncology
Background:
- Current platinum-based anticancer drugs like cisplatin cause severe side effects and systemic toxicity.
- There is a critical need for safer and more effective drug delivery systems for cancer treatment.
Purpose of the Study:
- To review the current advancements in silicon-containing nanocarriers conjugated with platinum-based drugs.
- To highlight the role of nano-chemistry in developing novel anticancer prodrugs.
Main Methods:
- Review of existing literature on silicon-based nanocarriers (silica, silsesquioxanes).
- Analysis of conjugation and complexation strategies between platinum drugs and silicon nanocarriers.
- Focus on nano-chemistry principles applied to prodrug design.
Main Results:
- Silicon nanocarriers demonstrate high stability, biocompatibility, and potential for prolonged drug release.
- These nanomaterials offer versatile surface chemistry for tailored drug delivery.
- Silicon-based platforms improve the efficacy of platinum-based anticancer agents.
Conclusions:
- Silicon-containing nanocarriers represent a promising strategy for developing safer and more effective anticancer prodrugs.
- Nano-chemistry is pivotal in designing advanced silicon-based drug delivery systems.
- This approach holds potential for improved cancer therapy with reduced toxicity.
